Staburo @ PSI/EFSPI Vaccines Statistics Workshop

Staburo @ PSI/EFSPI Vaccines Statistics Workshop

Staburo @ PSI/EFSPI Vaccines Statistics Workshop

On October 23, 2025, Staburo, represented by Tim Müller, attended the PSI/EFSPI Vaccines Statistics Workshop at the GSK site in Wavre. The workshop brought together a focused group of highly knowledgeable statisticians and researchers working in vaccines and infectious diseases. 

Tim enjoyed meeting familiar and new faces, and had engaging discussions with speakers and participants alike. Sessions on surrogate and correlates of protection, Bayesian methods, and modeling approaches sparked particularly interesting conversations. 

GSK was great at hosting the event on their site, providing an excellent setting for knowledge exchange and collaboration. Overall, it was an inspiring day that highlighted the exciting work happening in infectious disease statistics. Staburo is proud to contribute to this field and looks forward to continuing these discussions with peers and collaborators. 

 

Data analysis, clinical biostatistics and more.

Staburo contributes to bioinformatic analysis in a Phase 2 chronic kidney disease (CKD) study

Staburo contributes to bioinformatic analysis in a Phase 2 chronic kidney disease (CKD) study

Staburo contributes to bioinformatic analysis in a Phase 2 chronic kidney disease (CKD) study

We are pleased that part of our work got published as a scientific article in the International Journal of Molecular Sciences on November 7th, 2025.

In this publication, we supported the bioinformatic analysis in a study investigating the effect of Vicadrostat monotherapy or in combination with Empagliflozin on urinary extracellular vesicle microRNA expression.

Staburo assisted in data analysis and visualisation, as well as in biological interpretation, identifying the modulation of miRNA profiles under the treatments in the study, highlighting the potential use of microRNAs as biomarkers for disease activity and treatment response in CKD.

DOI: https://doi.org/10.3390/ijms262210810

Data analysis, clinical biostatistics and more.

Staburo contributes to bioinformatic analysis in psoriasis phase 2 study

Staburo contributes to bioinformatic analysis in psoriasis phase 2 study

Staburo contributes to bioinformatic analysis in psoriasis phase 2 study 

We are pleased that part of our work has been published as a letter to the author in the Journal of investigative dermatology. 

In this publication we supported the bioinformatic analysis in a study investigating the effect of spesolimab on microRNA expression in generalized pustular psoriasis (GPP). It was the first time investigating the role of microRNAs in both skin and blood samples of patients with GPP. 

Staburo assisted in data analysis and visualisation as well as in biological interpretation and identified a set of 5 core microRNA that showed consistent dysregulation in GPP and modulation upon spesolimab treatment. 

DOI: 10.1016/j.jid.2025.08.020     

Data analysis, clinical biostatistics and more.

Meet the Management – Lauri Õnnik– Director Data Management

Meet the Management – Lauri Õnnik– Director Data Management

Meet the Management – Lauri Õnnik– Director Data Management 

As Staburo continues to grow, so does our management team and with growth come new responsibilities and opportunities! We are excited to announce that Lauri Õnnik has been promoted to Director Data Management. 
We would like to introduce him as the newest member of our management team and give him the opportunity to share more about himself and his passions. 

Who are you?  

My name is Lauri Õnnik, and I am Director Data Management at Staburo. I joined the Staburo team in 2023 when Data Management services were introduced to the company’s portfolio. I studied Sports Science at the University of Tartu. 

Please tell us something about your area of work.  

Clinical Data Management focuses on collecting and cleaning clinical trial data ensuring the completeness and consistency of the data to be ready for programming and analysis.  

What are your goals for your role?  

My goal is to build a group of data management experts with a wide perspective on the field accompanied by strong collaboration both within the team but also across related functions. 

 

Would you like to learn more about the other directors? All previous interviews are linked below, offering insights into their stories and goals: Stefan Bentink, Habib Esmaeili, Katrin Frank, Lena Herich, Luciana Husfeld, Janine Roy, Laura Schlieker and Angelika Böhm. 

Data analysis, clinical biostatistics and more.

Staburo at Wiesn 2025

Staburo at Wiesn 2025

Staburo at Wiesn 2025

On 25 September 2025, the Staburo GmbH team came together to enjoy a fun evening at the Oktoberfest in Munich. This yearly tradition was a wonderful opportunity to connect beyond the usual work environment, as employees, including many of our remote colleagues, gathered in person to share an unforgettable day. 

Alongside a few clients, we enjoyed the unique Oktoberfest atmosphere with traditional Bavarian food, music and, of course, a few beers. The lively conversations and shared experiences highlighted the strong relationships that make collaboration at Staburo so successful. 

Some colleagues even embraced the festive spirit further by heading to the rollercoasters and rides after the tent celebrations. 

Events like these are an important part of our company culture, bringing people together and strengthening partnerships. We’re already looking forward to next year’s Wiesn! 

Data analysis, clinical biostatistics and more.